What is the official website of Accelerated Enrollment Solutions ?

The official website of Accelerated Enrollment Solutions is https://trialmed.com/.

What is Accelerated Enrollment Solutions's cybersecurity risk score?

Accelerated Enrollment Solutions has an AI-generated cybersecurity risk score of 756 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Accelerated Enrollment Solutions experienced?

According to Rankiteo, Accelerated Enrollment Solutions currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Accelerated Enrollment Solutions been affected by any supply chain cyber incidents ?

According to Rankiteo, Accelerated Enrollment Solutions has been affected by a supply chain cyber incident involving Fisher Healthcare, with the incident ID FISMIC1784032242.

Does Accelerated Enrollment Solutions have SOC 2 Type 1 certification ?

According to Rankiteo, Accelerated Enrollment Solutions is not certified under SOC 2 Type 1.

Does Accelerated Enrollment Solutions have SOC 2 Type 2 certification ?

According to Rankiteo, Accelerated Enrollment Solutions does not hold a SOC 2 Type 2 certification.

Does Accelerated Enrollment Solutions comply with GDPR ?

According to Rankiteo, Accelerated Enrollment Solutions is not listed as GDPR compliant.

Does Accelerated Enrollment Solutions have PCI DSS certification ?

According to Rankiteo, Accelerated Enrollment Solutions does not currently maintain PCI DSS compliance.

Does Accelerated Enrollment Solutions comply with HIPAA ?

According to Rankiteo, Accelerated Enrollment Solutions is not compliant with HIPAA regulations.

Does Accelerated Enrollment Solutions have ISO 27001 certification ?

According to Rankiteo,Accelerated Enrollment Solutions is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Accelerated Enrollment Solutions operate in ?

Accelerated Enrollment Solutions operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Accelerated Enrollment Solutions have ?

Accelerated Enrollment Solutions employs approximately 496 people worldwide.

Does Accelerated Enrollment Solutions own any subsidiaries ?

Accelerated Enrollment Solutions presently has no subsidiaries across any sectors.

How many LinkedIn followers does Accelerated Enrollment Solutions have ?

Accelerated Enrollment Solutions's official LinkedIn profile has approximately 32,927 followers.

What is the NAICS classification code for Accelerated Enrollment Solutions ?

Accelerated Enrollment Solutions is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Accelerated Enrollment Solutions have a Crunchbase profile ?

No, Accelerated Enrollment Solutions does not have a profile on Crunchbase.

Does Accelerated Enrollment Solutions have a LinkedIn profile ?

Yes, Accelerated Enrollment Solutions maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/accelerated-enrollment-solutions.

How many cybersecurity incidents has Accelerated Enrollment Solutions experienced ?

As of September 23, 2026, Rankiteo reports that Accelerated Enrollment Solutions has experienced 3 cybersecurity incidents.

How many peer or competitor companies does Accelerated Enrollment Solutions have ?

Accelerated Enrollment Solutions has an estimated 5,769 peer or competitor companies worldwide.

What types of cybersecurity incidents has Accelerated Enrollment Solutions faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Vulnerability.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

AES

Boost Score +25 with badge (5 left)

756

/1000

Fair

781

/1000

Fair

Accelerated Enrollment Solutions Vendor Cyber Rating & Cyber Score

trialmed.com

Add Your Compliance Badge

Accelerated Enrollment Solutions (AES) is now Trialmed. Follow us at our new home to understand how we're championing care in clinical research: https://www.linkedin.com/company/trialmed-solutions/ This account will not be active going forward.

AES

Accelerated Enrollment Solutions CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Thermo Fisher Scien...

Vulnerability

7/2026

THE1785781553

Fisher Healthcare

Breach

5/2024

Fisher Healthca...

FISMIC178403224...

Accelerated Enrollm...

Breach

7/2017

THE206072925

Loading…

A.I.

AES Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for AES

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Accelerated Enrollment Solutions in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Accelerated Enrollment Solutions in 2026.

Incident Types AES vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Accelerated Enrollment Solutions in 2026.

Incident History - AES (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Accelerated Enrollment Solutions Subsidiaries

AES

Pharmaceutical Manufacturing

Website: https://trialmed.com/

Company Size: 1,001-5,000 employees

PPDResearch Services

Thermo Fisher ScientificBiotechnology Research

PatheonPharmaceutical Manufacturing

Gallus BioPharmaceuticalsBiotechnology Research

Thermo ScientificBiotechnology Research

FEI CompanyNanotechnology Research

Accelerating MicroscopyBiotechnology

Unity Lab ServicesBiotechnology Research

Chromatography & Mass SpectrometryBiotechnology

Advancing MaterialsResearch Services

Fisher HealthcareHospitals and Health Care

Thermo Fisher Spectral CytometryBiotechnology Research

PPD™ Laboratory ServicesPharmaceutical Manufacturing

EvideraResearch Services

LiveTracker®Research Services

PPD™ Biotech SolutionsPharmaceutical Manufacturing

Loading…

Accelerated Enrollment Solutions Similar Companies

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Loading…

NEWS

Accelerated Enrollment Solutions CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 28, 2024 07:00 AM

Fastest Accelerated Online Bachelor’s of Cybersecurity

Want to earn an online bachelor's in cyber security, but need it quick? We rank the fastest online bachelor's degrees in cyber security in...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-95828

SUMMARY

A vulnerability was determined in Mstfakts College-Management-System. This affects the function session_start of the file Front-end/server.php of the component Authentication. Executing a manipulation can lead to session fixiation. It is possible to launch the attack remotely. The exploit has been publicly disclosed and may be utilized. This product takes the approach of rolling releases to provide continious delivery. Therefore, version details for affected and updated releases are not available. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-95820

SUMMARY

A vulnerability was found in anirbandutta9 College-Notes-Gallery up to 8c1cf3d98f30982d069c88ca172612c001eb39f6. Affected by this issue is some unknown functionality of the file /dashboard/userprofile.php?section=admin1. Performing a manipulation of the argument image results in unrestricted upload. It is possible to initiate the attack remotely. The exploit has been made public and could be used. This product is using a rolling release to provide continious delivery. Therefore, no version details for affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-61685

SUMMARY

ReactPress is a publishing system for React developers. Prior to version 3.7.0, ReactPress API list endpoints build TypeORM `QueryBuilder` conditions using unsanitized HTTP query parameter names as SQL column identifiers (e.g. `` `article.${key}` ``). TypeORM parameterizes values but not column names, allowing unauthenticated attackers to inject SQL through crafted query string keys. Version 3.7.0 contains a patch. As a workaround, allowlist allowed filter column names before interpolating into SQL.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-57576

SUMMARY

plone.app.dexterity is a content-type system for the Plone content management system, and plone.app.contenttypes provides Plone’s Dexterity-based content types. Plone.app.dexterity versions through 3.2.2, 4.0.0 through 4.1.2, and 5.0.0, and plone.app.contenttypes versions through 3.0.11, 4.0.0 through 4.0.9, and 5.0.0 are vulnerable to denial of service because an authenticated user can create content with excessively long titles, descriptions, or uploaded-file names, causing Plone to become unresponsive and potentially making the resulting content difficult to edit or delete. The vulnerability is patched in plone.app.dexterity versions 3.2.3, 4.1.3, and 5.0.1, and in plone.app.contenttypes versions 3.0.12, 4.0.10, and 5.0.1.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

CVE-2026-18176

SUMMARY

IBM Financial Transaction Manager (FTM) for RedHat OpenShift could allow a remote attacker to obtain sensitive information due to cleartext transmission of sensitive information.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7288641

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Accelerated Enrollment Solutions Vendor Cyber Rating & Cyber Score

AES A.I CyberSecurity Scoring

Accelerated Enrollment Solutions CyberSecurity News & History

AES Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for AES

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types AES vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - AES (X = Date, Y = Severity)

Accelerated Enrollment Solutions Subsidiaries

AES

Accelerated Enrollment Solutions Similar Companies

Sanofi

Servier

Torrent Pharmaceuticals Ltd

Zoetis

Merck

Zydus Group

MANKIND PHARMA LTD

MACLEODS PHARMACEUTICALS LTD.

Teva Pharmaceuticals

Accelerated Enrollment Solutions CyberSecurity News

Fastest Accelerated Online Bachelor’s of Cybersecurity

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Accelerated Enrollment Solutions CyberSecurity News & History

AES Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for AES

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types AES vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - AES (X = Date, Y = Severity)

Accelerated Enrollment Solutions Subsidiaries

AES

Accelerated Enrollment Solutions Similar Companies

Sanofi

Servier

Torrent Pharmaceuticals Ltd

Zoetis

Merck

Zydus Group

MANKIND PHARMA LTD

MACLEODS PHARMACEUTICALS LTD.

Teva Pharmaceuticals

Accelerated Enrollment Solutions CyberSecurity News

Fastest Accelerated Online Bachelor’s of Cybersecurity

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo